Vaccines against antimicrobial resistance.

Area of Science:

• Infectious Diseases
• Immunology
• Public Health

Background:

• Antimicrobial resistance (AMR) poses a significant global clinical and economic threat, projected to cause 10 million deaths annually by 2050.
• The escalating crisis necessitates sustainable prevention strategies to curb the spread of drug-resistant infections in both community and healthcare settings.

Purpose of the Study:

• To review existing vaccines effective in reducing the burden of AMR.
• To highlight the critical role of vaccine development in tackling AMR.
• To focus on the urgent need for vaccines against Clostridioides difficile and group B Streptococcus.

Main Methods:

• Literature review of existing bacterial and viral vaccines.
• Analysis of vaccine impact on infection rates and antibiotic consumption.
• Discussion of the pipeline for novel vaccines targeting AMR pathogens.

Main Results:

• Several existing vaccines demonstrate efficacy in mitigating the impact of AMR.
• Vaccines prevent infections, thereby reducing the need for antimicrobial interventions.
• Promising vaccine candidates for Clostridioides difficile and group B Streptococcus are nearing development.

Conclusions:

• Vaccines are a vital component of the strategy to combat antimicrobial resistance.
• Continued development and implementation of vaccines are essential for global health security.
• Targeted vaccine development for pathogens like Clostridioides difficile and group B Streptococcus holds significant promise for reducing AMR.